Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
May 06 2022 - 9:00AM
Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical
technology company focused on elevating the standard of care by
driving the evolution of digital health, today announced that it
has granted restricted stock unit awards to one (1) employee, who
was not an executive officer as an inducement for him to accept
employment with Surgalign, and representing the right to receive,
in the aggregate, up to 37,500 shares of Surgalign common stock.
The award was granted on May 2, 2022 and it was made under the
Surgalign Holdings, Inc. 2021 Inducement Plan. One-third of the
restricted stock units vest on the first anniversary of the date of
grant, and one-eighth of the remaining restricted stock units vest
on each subsequent quarterly anniversary of the date of grant, such
that the award will be fully vested on the third anniversary of the
date of grant, subject to continued employment through the
applicable vesting date.
The awards were approved by the independent
Compensation Committee of the Board of Directors of Surgalign
Holdings and were granted to the new employees as an inducement
material to their acceptance of employment with Surgalign pursuant
to Nasdaq rules.
About Surgalign Holdings, Inc.
Surgalign Holdings, Inc. is a global medical
technology company committed to the promise of digital health and
is building out its digital surgery platform to drive
transformation across the surgical landscape. Uniquely aligned and
resourced to advance the standard of care, the company is building
technologies surgeons will look to for what is truly possible for
their patients. Surgalign is focused on bringing surgeons solutions
that predictably deliver superior clinical and economic outcomes.
Surgalign markets products throughout the United States and in more
than 50 countries worldwide through an expanding network of top
independent distributors. Surgalign is headquartered in Deerfield,
IL, with commercial, innovation and design centers in San Diego,
CA, Warsaw and Poznan, Poland and Wurmlingen, Germany. Learn more
at www.surgalign.com and connect on
LinkedIn and Twitter.
Forward Looking Statement
This press release contains forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995. These forward-looking statements are based on
management’s current expectations, estimates and projections about
our industry, our management's beliefs and certain assumptions made
by our management. Words such as "anticipates," "expects,"
"intends," "plans," "believes," "seeks," "estimates," variations of
such words and similar expressions are intended to identify such
forward-looking statements. These statements are not guarantees of
future performance and are subject to risks and uncertainties,
including the risks described in public filings with the U.S.
Securities and Exchange Commission (SEC). Our actual results may
differ materially from the anticipated results reflected in these
forward-looking statements. Copies of the company's SEC filings may
be obtained by contacting the company or the SEC or by visiting
Surgalign's website at www.surgalign.com or the SEC's
website at www.sec.gov.
Investor and Media Contact:Mike
VallieIR@surgalign.com+1 443 213 0499
Surgalign (NASDAQ:SRGA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Surgalign (NASDAQ:SRGA)
Historical Stock Chart
From Apr 2023 to Apr 2024